|
Volumn 288, Issue 5474, 2000, Pages 2150-2153
|
Ground zero: AIDS research in Africa
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
FLUCONAZOLE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
AFRICA;
CLINICAL FEATURE;
CLINICAL RESEARCH;
COST CONTROL;
DISEASE COURSE;
ENDEMIC DISEASE;
HEALTH CARE FINANCING;
HEALTH PROGRAM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE;
INFECTION CONTROL;
INFECTION RATE;
INTERNATIONAL COOPERATION;
PRIORITY JOURNAL;
REVIEW;
VACCINATION;
VIRUS TRANSMISSION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AFRICA SOUTH OF THE SAHARA;
ANTI-HIV AGENTS;
CONGRESSES;
DISEASE OUTBREAKS;
FEMALE;
FINANCIAL SUPPORT;
HIV INFECTIONS;
HUMANS;
INTERNATIONAL COOPERATION;
MALE;
RESEARCH;
SOCIOECONOMIC FACTORS;
HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 0034705606
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.288.5474.2150 Document Type: Review |
Times cited : (17)
|
References (0)
|